Motion Medicine
- Manufacturer
- Motion Medicine Inc. | Nutri-Dyn Products Ltd. dba Professional Health Products | Enterprises ImportFab Inc.
- Effective date
- 2022-10-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 39
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:52:15
Label at a glance#
ProductMotion Medicine
Active ingredientCAMPHOR (SYNTHETIC), MENTHOL
Label structure9 sections
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients (Percent by weight) Purpose
Menthol 4.0% ............................Analgesic (Pain reliever)
Camphor 4.0% ...........................Analgesic (Pain reliever)
INDICATIONS & USAGE SECTION
For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains, etc.
WARNINGS SECTION
Warnings
- Avoid getting into eyes or on mucous membranes.
- If condition worses, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor.
- Do not apply to wounds or damaged skin. Do not bandage tightly.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children
- Use only as directed.
- If swallowed, get medical help or contact a Poison Control center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
Adults and children 12 years of age or older: Rub this soothing cream on the affected area not more than 3 to 4 times daily.
Children under the age of 12: Do not use, consult a doctor.
INACTIVE INGREDIENT SECTION
Water purified, methylsulfonylmethane (MSM), cetyl alcohol, glyceryl stearate, steareth-100, glycerin, glucosamine sulfate,
stearyl alcohol, polysorbate 20, urea, phenoxyethanol, caprylyl glycol, sorbic acid, polyacrylamide, C-13-14 isoparaffin, laureth-7,
eucalyptus oil, grape seed oil, methyl salicylate, tocopheryl acetate, alcohol denatured, thymol, lavender oil, chondroitin sulfate.
OTC - PURPOSE SECTION
Pain Reliever
REFERENCES SECTION
Distributed by:
Motion Medicine Inc.
84 Sunmeadows Crescent SE
Calgary, AB CANADA T2X 3H3
1-866-972-8466
120g
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Eases pain, improves movement, and is highly effective
Topical Remedy
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50963-809-05 | 2024-01-30 | C162847 | 48780-1 | 1030e365-533e-111a-e063-dadaa90a10e2 | 69c06d8d-5363-497e-b11b-fdf11891f647 |
| 50963-809-16 | 2024-01-30 | C162847 | 48780-1 | 1030e365-533e-111a-e063-dadaa90a10e2 | 69c06d8d-5363-497e-b11b-fdf11891f647 |
| 50963-809-88 | 2024-01-30 | C162847 | 48780-1 | 1030e365-533e-111a-e063-dadaa90a10e2 | 69c06d8d-5363-497e-b11b-fdf11891f647 |
| 50963-809-94 | 2024-01-30 | C162847 | 48780-1 | 1030e365-533e-111a-e063-dadaa90a10e2 | 69c06d8d-5363-497e-b11b-fdf11891f647 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (SYNTHETIC) | ACTIVE INGREDIENT | 5TJD82A1ET | 23 | |
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 23 | |
| CAMPHOR (SYNTHETIC) | ACTIVE MOIETY | 5TJD82A1ET | 23 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 23 | |
| .ALPHA.-TOCOPHEROL, DL- | INACTIVE INGREDIENT | 7QWA1RIO01 | 23 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 23 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 23 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 23 | |
| CHONDROITIN SULFATE SODIUM (BOVINE) | INACTIVE INGREDIENT | 8QTV3DTT8W | 23 | |
| DIMETHYL SULFONE | INACTIVE INGREDIENT | 9H4PO4Z4FT | 23 | |
| EUCALYPTUS OIL | INACTIVE INGREDIENT | 2R04ONI662 | 23 | |
| GLUCOSAMINE SULFATE | INACTIVE INGREDIENT | 1FW7WLR731 | 23 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 23 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 23 | |
| GRAPE SEED OIL | INACTIVE INGREDIENT | 930MLC8XGG | 23 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 23 | |
| METHYL SALICYLATE | INACTIVE INGREDIENT | LAV5U5022Y | 23 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 23 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 23 | |
| SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER (1:1; 90000-150000 MPA.S) | INACTIVE INGREDIENT | 5F4963KLHS | 23 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | 23 | |
| STEARETH-100 | INACTIVE INGREDIENT | 4OH5W9UM87 | 23 | |
| STEARYL ALCOHOL | INACTIVE INGREDIENT | 2KR89I4H1Y | 23 | |
| THYMOL | INACTIVE INGREDIENT | 3J50XA376E | 23 | |
| UREA | INACTIVE INGREDIENT | 8W8T17847W | 23 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 23 |
Products#
Every source-derived product name is available through these pages.
- Motion Medicine
- Camphor, Menthol
- WATER
- DIMETHYL SULFONE
- CETYL ALCOHOL
- GLYCERYL STEARATE SE
- STEARETH-100
- GLYCERIN
- GLUCOSAMINE SULFATE
- STEARYL ALCOHOL
- POLYSORBATE 20
- UREA
- PHENOXYETHANOL
- CAPRYLYL GLYCOL
- SORBIC ACID
- POLYACRYLAMIDE (1500 MW)
- C13-14 ISOPARAFFIN
- LAURETH-7
- EUCALYPTUS OIL
- GRAPE SEED OIL
- METHYL SALICYLATE
- .ALPHA.-TOCOPHEROL ACETATE
- ALCOHOL
- THYMOL
- LAVENDER OIL
- CHONDROITIN SULFATE SODIUM (BOVINE)
- CAMPHOR (SYNTHETIC)
- MENTHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50963-809 | 50963-809-94, 50963-809-05, 50963-809-16, 50963-809-88 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CREAM / TOPICAL | 108 mg | ||
| .ALPHA.-TOCOPHEROL, DL- | .ALPHA.-TOCOPHEROL, DL- | 7QWA1RIO01 | SUSPENSION / ORAL | 0.01 mg/1ml | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, EXTENDED RELEASE / ORAL | 4.2 mg | ||
| .ALPHA.-TOCOPHEROL, DL- | .ALPHA.-TOCOPHEROL, DL- | 7QWA1RIO01 | INJECTION, EMULSION / INTRAVENOUS | 178 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | CREAM / TOPICAL | 162000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| .ALPHA.-TOCOPHEROL, DL- | .ALPHA.-TOCOPHEROL, DL- | 7QWA1RIO01 | SOLUTION / ORAL | 4 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / SUBCUTANEOUS | NA | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | SUSPENSION / ORAL | 40 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| .ALPHA.-TOCOPHEROL, DL- | .ALPHA.-TOCOPHEROL, DL- | 7QWA1RIO01 | TABLET / ORAL | 0.12 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, FILM COATED / ORAL | 0.35 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| .ALPHA.-TOCOPHEROL, DL- | .ALPHA.-TOCOPHEROL, DL- | 7QWA1RIO01 | SYSTEM / TRANSDERMAL | 0.14 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, CHEWABLE / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| .ALPHA.-TOCOPHEROL, DL- | .ALPHA.-TOCOPHEROL, DL- | 7QWA1RIO01 | CAPSULE / ORAL | 90 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| METHYL SALICYLATE | METHYL SALICYLATE | LAV5U5022Y | TABLET / ORAL | 10 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / AURICULAR (OTIC) | 0.1 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| METHYL SALICYLATE | METHYL SALICYLATE | LAV5U5022Y | POWDER / TOPICAL | NA | ||
| UREA | UREA | 8W8T17847W | TABLET, EFFERVESCENT / ORAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| .ALPHA.-TOCOPHEROL, DL- | .ALPHA.-TOCOPHEROL, DL- | 7QWA1RIO01 | TABLET, CHEWABLE / ORAL | 0.02 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | SOLUTION / ORAL | 80 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / SUBCUTANEOUS | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | LOTION / TOPICAL | 2000 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| UREA | UREA | 8W8T17847W | TABLET, COATED / ORAL | 0.02 mg | ||
| UREA | UREA | 8W8T17847W | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ea508ab6-0578-7db4-e053-2995a90aa038 | 69c06d8d-5363-497e-b11b-fdf11891f647 | 2022-10-05 | Warnings | ea508ab6-0578-7db4-e053-2995a90aa038 69c06d8d-5363-497e-b11b-fdf11891f647 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.